During the past decade, Obudai Egeszsegugyi Centrum Kft. conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 19 clinical trials were completed, i.e. on average, 47.5% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 18 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Obudai Egeszsegugyi Centrum Kft." #1 sponsor was "Janssen Research & Development, LLC" with 8 trials, followed by "Amgen" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Takeda" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Obudai Egeszsegugyi Centrum Kft." #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "OCT Clinical Trials" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Obudai Egeszsegugyi Centrum Kft." are "Ulcerative Colitis" (8 trials), "Crohn's Disease" (5 trials), "Crohn Disease" (4 trials), "Colitis, Ulcerative" (3 trials) and "Rheumatoid Arthritis" (3 trials). Many other conditions were trialed in "Obudai Egeszsegugyi Centrum Kft." in a lesser frequency.

Most popular intervention types in "Obudai Egeszsegugyi Centrum Kft." are "Drug" (41 trials), "Other" (5 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Guselkumab" (4 trials), "Aticaprant" (2 trials), "Etanercept" (2 trials) and "Etrasimod" (2 trials). Other intervention names were less common.

The vast majority of trials in "Obudai Egeszsegugyi Centrum Kft." are 41 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Obudai Egeszsegugyi Centrum Kft.". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Obudai Egeszsegugyi Centrum Kft., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Obudai Egeszsegugyi Centrum Kft., 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".